|
2024
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. Medical informational services, includin... |
|
|
Invention
|
Compounds and methods for the targeted degradation of androgen receptor. This disclosure pertains... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Combinations of estrogen receptor degraders and cdk7 inhibitors for the treatment of cancer. Disc... |
|
|
Invention
|
Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, a... |
|
|
Invention
|
Solid oral dosage forms of estrogen receptor degraders. Disclosed herein are solid oral dosage fo... |
|
|
Invention
|
Combinations of estrogen receptor degraders and akt inhibitors. Disclosed herein are methods for ... |
|
|
Invention
|
Indazole based compounds and associated methods of use.
Bifunctional compounds, which find utili... |
|
|
Invention
|
Bavdegalutamide for treating prostate cancer without ar l702h mutation. This disclosure pertains ... |
|
|
Invention
|
Use of an androgen receptor degrader protac for the treatment of prostate cancer. The present app... |
|
|
Invention
|
Egfr proteolysis targeting chimeric molecules and associated methods of use.
The present inventi... |
|
|
Invention
|
Crystalline forms of a compound for the targeted degradation of the androgen receptor.
The prese... |
|
|
Invention
|
Crystalline forms of a compound for the targeted degradation of the androgen receptor. The presen... |
|
|
Invention
|
Dosage regimens of estrogen receptor degraders. Disclosed herein are methods for treating cancer ... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use.
Bifunctional compounds, which find... |
|
|
Invention
|
Dosage regimens of estrogen receptor degraders in combination with an mtor inhibitor. Disclosed h... |
|
|
Invention
|
Cereblon-based kras degrading protacs and uses related thereto.
Provided herein are compounds th... |
|
|
Invention
|
Cereblon-based kras degrading protacs ans uses related thereto. Provided herein are compounds tha... |
|
|
Invention
|
Pharmaceutical formulations of an androgen receptor-targeting protein degrader. The present discl... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use.
This application pertains to the u... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use. This application pertains to the us... |
|
2023
|
Invention
|
Method of treating breast cancer. The invention relates to a method for treating cancer in a subj... |
|
|
Invention
|
Casitas b-lineage lymphoma protooncogene b (cbl-b) degrading compounds and associated methods of ... |
|
|
Invention
|
Selective modulators of mutant lrrk2 proteolysis and associated methods of use.
Bifunctional com... |
|
|
Invention
|
Rapid accelerated fibrosarcoma (raf) degrading compounds and associated methods of use.
or pharm... |
|
|
Invention
|
Compounds and methods for the targeted degradation of androgen receptor.
This disclosure pertain... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use.
This disclosure pertains to bifunc... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use. This disclosure pertains to bifunct... |
|
|
Invention
|
Methods of treating prostate cancer.
The present application relates to treating and/or preventi... |
|
|
Invention
|
Tau-protein targeting compounds and associated methods of use.
The present disclosure relates to... |
|
|
Invention
|
Modulators of alpha-synuclein proteolysis and associated methods of use.
The present disclosure ... |
|
|
Invention
|
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use.
or pha... |
|
|
Invention
|
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use. Provide... |
|
|
Invention
|
Leucine rich repeat kinase 2 (lrrk2) degrading compounds and associated methods of use. The prese... |
|
|
Invention
|
Vepdegestrant for use in treating cancer. Disclosed herein are methods for treating cancer compri... |
|
|
Invention
|
Imide-based modulators of proteolysis and associated methods of use.
The description relates to ... |
|
|
Invention
|
Modulators of tyk2 proteolysis and associated methods of use. Bifunctional compounds, which find ... |
|
|
Invention
|
Compounds and methods for the targeted degradation of irak-4. e.g.e.g., rheumatoid arthritis). |
|
|
Invention
|
Breast cancer treatment method. Disclosed herein are methods for treating breast cancer (e.g., tr... |
|
|
Invention
|
Compounds and methods for the targeted degradation of androgen receptor. The present disclosure r... |
|
|
Invention
|
Bavdegalutamide and combinations thereof for use in treating prostate cancer. This disclosure per... |
|
|
Invention
|
Brm targeting compounds and associated methods of use.
The present disclosure relates to bifunct... |
|
|
Invention
|
Dgk targeting compounds and uses thereof. Disclosed herein are compounds of Formula (A), or a pha... |
|
|
Invention
|
Compounds and methods for the targeted degradation of kras. Bifunctional compounds, which find ut... |
|
2022
|
Invention
|
Compounds and methods for the targeted degradation of the androgen receptor.
The present inventi... |
|
|
Invention
|
Cereblon ligands and bifunctional compounds comprising the same.
The description relates to cere... |
|
|
Invention
|
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders.
The... |
|
|
Invention
|
Compounds and methods for the targeted degradation of bromodomain- containing proteins. The prese... |
|
|
Invention
|
Compounds and methods for the enhanced degradation of targeted proteins.
The present invention r... |
|
|
P/S
|
Pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, ... |
|
|
P/S
|
Pharmaceutical preparations for use in treating oncology,
immunology, and inflammatory diseases,... |
|
2021
|
P/S
|
Agricultural products development |
|
|
P/S
|
Bi-functional small molecules that mediate targeted protein degradation through the ubiquitin pro... |
|
2020
|
P/S
|
Pharmaceutical products development of new small molecules aimed at degrading disease-causing cel... |
|
2018
|
P/S
|
Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular pro... |
